Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for G2213. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
20
Median % of Medicare
81.2%
Rate range
$1.00 - $83.42
G2213 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| California | $58.30 | 87.7% | -- | 2026 |
| Delaware | $64.66 | 97.3% | -- | 2026 |
| Hawaii | $60.24 | 90.6% | -- | 2025 |
| Iowa | $53.90 | 81.1% | -- | 2024 |
| Idaho | $53.96 | 81.2% | Not required | 2026 |
| Indiana | $59.41 | 89.4% | -- | 2025 |
| Kansas | $40.31 | 60.6% | -- | 2021 |
| Maine | $45.72 | 68.8% | -- | 2026 |
| Michigan | $42.39 | 63.8% | -- | 2026 |
| Minnesota | $48.88 | 73.5% | -- | 2026 |
| Montana | $83.42 | 125.5% | -- | 2026 |
| New Hampshire | $69.44 | 104.5% | Not required | 2026 |
| New Jersey | $33.44 | 50.3% | Not required | 2026 |
| New Mexico | $66.56 | 100.1% | -- | 2023 |
| Oklahoma | $59.44 | 89.4% | -- | 2026 |
| Oregon | $52.96* | 79.7% | -- | 2026 |
| Pennsylvania | $1.00 | 1.5% | -- | 2021 |
| Virginia | $68.72 | 103.4% | -- | 2022 |
| Washington | $39.18 | 58.9% | -- | 2026 |
| West Virginia | $47.34 | 71.2% | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related physician codes
- 10004 - Needle biopsy without imaging, each added lesion
- 10005 - Needle biopsy with ultrasound guidance, first lesion
- 10006 - Needle biopsy with ultrasound guidance, each added lesion
- 10007 - Needle biopsy with fluoroscopic guidance, first lesion
- 10009 - Needle biopsy with CT guidance, first lesion
- 10011 - Needle biopsy with MRI guidance, first lesion
- 10012 - Needle biopsy with MRI guidance, each added lesion
- 10021 - Fine needle aspiration biopsy, first lesion, no imaging
All 17 codes from G2010 to G2252 or every physician code by number.
Frequently asked questions
How much does Medicaid pay for G2213?
20 state Medicaid programs publish a fee-for-service rate for G2213 (initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)), ranging from $1.00 in Pennsylvania to $83.42 in Montana, with a median of 81.2% of the national Medicare amount. The full table on this page lists every publishing state's current rate.
Which state pays the most for G2213?
Montana publishes the highest Medicaid rate for G2213 at $83.42 (125.5% of the national Medicare amount). Pennsylvania publishes the lowest at $1.00.
Does G2213 require prior authorization under Medicaid?
No publishing state flags G2213 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.